EU regulator begins real-time review of GSK-Vir's COVID-19 antibody drug

Retrieved on: 2021-05-07 09:11:15

Tags for this article:

Click the tags to see associated articles and topics

EU regulator begins real-time review of GSK-Vir's COVID-19 antibody drug. View article details on hiswai:

Excerpt

... review of GSK and Vir Biotechnology's antibody treatment for COVID-19, formally kicking off the process for a potential European Union approval.

Article found on: www.reuters.com